Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting

Open access
Sirica, Alphonse E., Gores, Gregory J.·2014·Hepatology

Abstract

holangiocarcinomas are usually characterized by a prominent desmoplastic and hypovascularized stroma.However, the biological significance and clinical impact of the desmoplastic stroma in cholangiocarcinoma is only just beginning to be addressed at the cellular and molecular levels.Nevertheless, there is now increasing evidence to suggest that the desmoplastic reaction, marked by a dramatic accumulation of a-smooth muscle actin positive cancerassociated fibroblasts (a-SMA1CAFs) with increased production of extracellular matrix proteins, proinvasive growth factors and cytokines, antiangiogenic factors, and matrix modifying enzymes may be playing a crucial role in promoting enhanced malignant behavior and therapeutic resistance in cholangiocarcinoma. 1 In this review we highlight current findings on the potential prognostic value of a-SMA1CAFs, tumor-associated macrophages, and select related blood and serum markers associated with the desmoplastic reaction in predicting cholangiocarcinoma progression and patient survival rates.We also describe recent experimental approaches to prevent cholangiocarcinoma by reducing hepatic fibrosis.Last, we discuss the potential merits and challenges of a-SMA1CAF depletion as a novel strategy for cholangiocarcinoma therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.26762

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 217

Metadata

Authors
Sirica, A. E., & Gores, G. J.
Venue
Hepatology
Published
2014-06
Volume
59
Issue
6
Pages
2397-2402
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2066967801
Cited by
217
References
2
FWCI
6.59
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.